Janagliflozin

Janagliflozin is a medication used for the treatment of Type 2 diabetes. It belongs to the class of drugs known as SGLT2 inhibitors, which work by preventing the kidneys from reabsorbing glucose back into the blood, thereby promoting the excretion of glucose through urine.

Mechanism of Action[edit | edit source]

Janagliflozin works by inhibiting the SGLT2 protein in the kidneys. This protein is responsible for approximately 90% of the reabsorption of glucose from the glomerular filtrate back into the blood. By inhibiting this protein, Janagliflozin causes an increase in the excretion of glucose in the urine, thereby reducing blood glucose levels.

Uses[edit | edit source]

Janagliflozin is used in the management of Type 2 diabetes. It is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Side Effects[edit | edit source]

Common side effects of Janagliflozin include urinary tract infections, increased urination, and yeast infections in women. Serious side effects may include Ketoacidosis, kidney problems, and low blood sugar.

Contraindications[edit | edit source]

Janagliflozin is contraindicated in patients with severe renal impairment, end-stage renal disease, or dialysis. It is also contraindicated in patients with a history of hypersensitivity reaction to Janagliflozin.

Interactions[edit | edit source]

Janagliflozin may interact with other medications such as diuretics, insulin, and sulfonylureas. It is important to inform your healthcare provider about all the medications you are currently taking.

See Also[edit | edit source]

Janagliflozin Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.